ENSURING MEDICATION QUALITY: THE CRUCIAL ROLE OF GMP RULES AND STANDARDS - A CASE STUDY ON BAYAN MEDICAL LLC AND THE IMPACT OF UZBEKISTAN'S PHARMACEUTICAL REFORMS
;
GMP rules, Medication production, Quality control, Bayan Medical LLC, Pharmaceutical industry, Global statistics, Shavkat Mirziyoyev, Uzbekistan, Pharmaceutical reforms.Abstrak
This scientific article delves into the significance of Good Manufacturing Practice (GMP) rules and standards in maintaining the quality control of medication production. Using Bayan Medical LLC as a case study, we explore the global statistics related to GMP standards, emphasizing their pivotal role in ensuring the safety and efficacy of pharmaceutical products. Additionally, we discuss how President Shavkat Mirziyoyev's reforms in Uzbekistan are reshaping the pharmaceutical industry by mandating GMP compliance for all manufacturers.
Iqtiboslar
World Health Organization. (2003). WHO Good Manufacturing Practices for Pharmaceutical Products. Geneva: World Health Organization. [1]
U.S. Food and Drug Administration. (2020). Current Good Manufacturing Practice (CGMP) Regulations. Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations [2]
European Medicines Agency. (2021). Good Manufacturing Practice (GMP). Retrieved from https://www.ema.europa.eu/en/human-regulatory/post-authorisation/compliance/good-manufacturing-practice-gmp [3]
President of Uzbekistan. (2023). Presidential Decree on Mandatory GMP Compliance for Pharmaceutical Manufacturers in Uzbekistan. Tashkent: Government of Uzbekistan. [4]
